DexCom, Inc. reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was USD 698.2 million compared to USD 568.9 million a year ago. Net loss was USD 19.4 million compared to net income of USD 355.2 million a year ago.

Basic loss per share from continuing operations was USD 0.05 compared to basic earnings per share from continuing operations of USD 0.925 a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to diluted earnings per share from continuing operations of USD 0.87 a year ago.